Capitulo1
Capitulo2
Capitulo3
Capitulo4
Capitulo5
Capitulo6
Capitulo7
Capitulo8
Capitulo2
Capitulo3
Capitulo11
Capitulo12
Capitulo13
Capitulo14
Capitulo15
Capitulo16
Capitulo17

1. American Diabetes Association: Hyperglycemic crises in patients withdiabetes mellitus. Diabetes Care 2001, 24:1992.

2. Glaser N, Barnett P, McCaslin I, et al.: Risk factors for cerebral edema inchildren with diabetic ketoacidosis. N Engl J Med.: 2001, 344:264–269.

3. Roe TF, Crawford TO, Huff KR, et al.: Brain infarction in children withdiabetic ketoacidosis. J Diabetes Complications 1996, 2:100–108.

4. The International Society for Pediatric and Adolescent Diabetes (ISPAD)Consensus Guidelines for the Management of Type 1 Diabetes Mellitusin Children and Adolescents, 2000, Medical Forum International,TheNetherlands.

5. Kaufman FR, Halvorson M:The treatment and prevention of diabeticketoacidosis in children and adolescents with type 1 diabetes mellitus.Pediatric Annals 1999, 28:9.

6. Karvonen M,Viik-Kajander M, Moltchanova E, et al.: Incidence of childhoodtype 1 diabetes worldwide. Diabetes Care 2000, 23:1516–1526.

7. Diabetes Control and Complications Trial Research Group: Effect ofintensive diabetes treatment in the development and progression oflong-term complications in adolescents with insulin-dependent diabetes.J Pediatr 1994, 125:177–188.

8. Kaufman FR: Diabetes in children and adolescents: prevention and treatmentof diabetes and its complications. Med Clin North Am 1998,82:721–738.

9. White NH, Cleary PA, Dahms W, et al.: Beneficial effects of intensivetherapy of diabetes during adolescence: outcomes after the conclusionof the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001,139:804–812.

10. Donaghue KC, Fung ATW, Hing S, et al.:The effect of prepubertaldiabetes duration on diabetes: microvascular complication in early andlate adolescence. Diabetes Care 1997, 20:77–80.

11. Buckingham BA, Bluck B,Wilson DM: Intensive diabetes management inpediatric patients. Curr Diabetes Rep 2001, 1:111–118.

12. Kaufman FR, Halvorson M, Carpenter S: Use of a plastic insulin dosageguide to correct blood glucose levels out of the target range and forcarbohydrate counting in subjects with type 1 diabetes. Diabetes Care1999, 22:1252–1257.

13. Chase HP, Kim LM, Owen SL, et al.: Continuous subcutaneous glucosemonitoring in children with type 1 diabetes. Pediatrics 2002,107:222–226.

14. Kaufman FR, Halvorson M, Carpenter S, et al.: Insulin pump therapy inyoung children with diabetes. Diabetes Spectrum 2001, 14:84–89.

15. Kaufman FR, Gibson LC, Halvorson M, et al.:A pilot study of the continuousglucose monitoring system. Diabetes Care 2001, 24:2030–2034.

16. Levine BS,Anderson BJ, Butler DA, et al.: Predictors of glycemic controland short-term adverse outcomes in youth with type 1 diabetes. JPediatr 2001, 139:197–203.

17. Care of children with diabetes in the school and day care setting.American Diabetes Association. Diabetes Care 1999, 22:163–166.

18. Brink SJ: Limited Joint Mobility. In Pediatric and Adolescent DiabetesMellitus. Edited by Brink SJ. Chicago:Year Book Medical Publishers;1987:305–312.

19. Infante JR, Rosenbloom AL, Silverstein JH, et al.: Changes in frequencyand severity of limited joint mobility in children with type 1 diabetesmellitus between 1976–1978 and 1998. J Pediatr 2001, 138:33–37.DIABETES DA INFΒNCIA 241

20. The American Diabetes Association Clinical Practice Recommendationsfor 2001. Diabetes Care 24:S1–S126.

21. Kaufman FR, Halvorson M: New trends in managing type 1 diabetes.Contemp Pediatr 1999, 16:112–123.

22. Schiffrin A: Psychosocial issues in pediatric diabetes. Curr Diabetes Rep2001, 1:33–40.

23. Kaufman FR, Halvorson M, Miller D, et al.: Insulin pump therapy in type 1pediatric patients: now and into the year 2000. Diabetes Metab Res Rev1999, 15:338–352.

24. Hoey H,Aanstoot HJ, Chiarelli F, et al.: Good metabolic control isassociated with better quality of life in 2,101 adolescents with type 1diabetes. Diabetes Care 2001, 24:1923–1928.

25. Silverstein JH, Rosenbloom AL:Type 2 diabetes in children. Curr DiabetesRep 2001, 1:19–27.

26. Type 2 diabetes in children and adolescents.American DiabetesAssociation. Diabetes Care 2000, 23:381–389.

27. Silverstein JH, Rosenbloom AL:Treatment of type 2 diabetes mellitus inchildren and adolescents. J Pediatr Endocrinol Metab 2000, 13:1402–1409.

28. Stuart CA, Pate CJ, Peters EJ: Prevalence of acanthosis nigricans in anunselected population. Am J Med 1989, 87:269–272.

29. CDC Body mass index-for-age percentiles.Available at:http://www.cdc.gov/nchs/about/major/nhanes/growthcharts/set1.Accessed April 23, 2001.

30. CDC/National Center for Health Statistics. Prevalence of overweightamong children and adolescents.Available at:http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm.Accessed April 23, 2002.

31. Jones KL,Arslanian S, Peterokova VA, et al.: Effect of metformin in pediatric patients with type 2 diabetes. Diabetes Care 2002, 25:89–94.

 voltar